Abstract: UV, LED, and UV/LED hybrid gel curing lamps which lessen the exposure to radiation from gel manicures and pedicures are disclosed. The lamp exposes only the fingertips or toetips to the radiation, thus lessening the total exposure to the user. This decrease in exposure prevents DNA damage to skin. Additionally, the present invention features a proper gel pedicure lamp which extends across a pedicure bowl so as to provide for the safety and comfort of the user.

Abstract: UV, LED, and UV/LED hybrid gel curing lamps which lessen the exposure to radiation from gel manicures and pedicures are disclosed. The lamp exposes only the fingertips or toetips to the radiation, thus lessoning the total exposure to the user. This decrease in exposure prevents DNA damage to skin. Additionally, the present invention features a proper gel pedicure lamp which extends across a pedicure bowl so as to provide for the safety and comfort of the user.

Abstract: The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purify and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders.

Abstract: The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purify and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders.

Abstract: The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purify and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders.

Abstract: The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purity and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders.

Abstract: The present invention is concerned with the use of 1,25-dihydroxy-16,23Z-diene-26,27-hexafluoro-19-nor vitamin D3 for the manufacture of a medicament for the prevention and/or treatment of autoimmune diabetes as well as for the manufacture of a medicament for preventing and/or treating allograft rejection, it is further concerned with a method for preventing and/or treating such diseases by administering 1,25-dihydroxy-16,23Z-diene-26,27-hexafluoro-19-nor vitamin D3 in an amount effective to prevent and/or to treat such diseases alone or in combination with other immunosuppressive agents.